Owing to recent medical and technological advances in neonatal care, infants born extremely premature have increased survival rates 1,2 . After birth, these infants are at high risk of hypoxic episodes because of lung immaturity, hypotension and lack of cerebral-flow regulation, and can develop a severe condition called encephalopathy of prematurity 3 . Over 80% of infants born before post-conception week 25 have moderateto-severe long-term neurodevelopmental impairments 4 
. The susceptible cell types in the cerebral cortex and the molecular mechanisms underlying associated gray-matter defects in premature infants remain unknown. Here we used human three-dimensional brain-region-specific organoids to study the effect of oxygen deprivation on corticogenesis. We identified specific defects in intermediate progenitors, a cortical cell type associated with the expansion of the human cerebral cortex, and showed that these are related to the unfolded protein response and changes. Moreover, we verified these findings in human primary cortical tissue and demonstrated that a small-molecule modulator of the unfolded protein response pathway can prevent the reduction in intermediate progenitors following hypoxia. We anticipate that this human cellular platform will be valuable for studying the environmental and genetic factors underlying injury in the developing human brain.
Extremely premature birth (before post-conception week (PCW) 28) coincides with critical biological events in the development of the central nervous system, including the formation of the expanded human cerebral cortex. Encephalopathy of prematurity is characterized by gray-and white-matter abnormalities and a reduction in cortical volume that correlates with neurodevelopmental outcomes, including cognitive and behavioral disorders 1 . A common pathogenic factor in encephalopathy of prematurity appears to be perinatal hypoxia 5 (often considered as decreases in the partial pressure of oxygen (Po 2 ) below 40 mm Hg). However, the cellular substrates and the molecular mechanisms by which changes in oxygen tension lead to cortical gray-matter defects in extremely premature infants are still not understood. This is primarily due to challenges in directly investigating the preterm human brain and difficulties in recapitulating the trajectory of human brain development and maturation in other species. Moreover, the unique cellular and molecular features underlying cortical development in humans 6 underscore the need for personalized human models of brain development. Recent advances in cell-reprogramming technologies as well as three-dimensional (3D) cell-differentiation methods make possible the non-invasive derivation of structures resembling regions of the developing human brain 7 .
Here we leveraged a method that we have previously described [8] [9] [10] to develop an in vitro human cellular model of hypoxic encephalopathy of prematurity. To achieve this, we differentiated human induced pluripotent stem (hiPS) cells into brain-region-specific organoids called human cortical spheroids (hCS) [9] [10] [11] . After approximately 10 weeks in vitro, hCS transcriptionally resemble the cerebral cortex at midgestation 9, 10 , which approximately corresponds to extreme prematurity. This developmental stage is characterized by extensive proliferation and neurogenesis in the cerebral cortex-a process that continues into the third trimester of pregnancy [12] [13] [14] . We exposed hCS to low oxygen concentrations in vitro and found a reduction in a specific population of cortical progenitors that are thought to contribute to the expansion of the primate cerebral cortex. Moreover, we found that pharmacologically modulating the unfolded protein response (UPR) can prevent this defect, and we used human primary tissue to validate these findings.
To develop a model of hypoxia during human corticogenesis, we differentiated hCS from five hiPS cell lines derived from four healthy subjects ( Fig. 1a and Supplementary Table 1) . We used a gas control chamber to expose hCS at approximately day 75 of differentiation to low oxygen tension (<1%) for 48 h, followed by reintroduction to 21% O 2 . To monitor changes in Po 2 in hCS, we used a needle-type fiber-optic oxygen microsensor. At the surface of hCS, the Po 2 was approximately 85 mm Hg, which is similar to Po 2 in arterial blood, while in the center values were on average above 62 mm Hg (Fig. 1b and Extended Data Fig. 1a ). Exposure to <1% O 2 for 48 h resulted in a drop to approximately 25 mm Hg at the hCS surface and approximately 20 mm Hg in the center of hCS, which is below the critical oxygen tension in the brain (P < 0.0001) 15 . WholehCS western blot analysis demonstrated that hypoxia-inducible factor-1 alpha (HIF-1α), a key oxygen-labile protein in the hypoxia pathway, stabilized at 48 h in low oxygen (P = 0.02) and returned to previous levels following 72 h of reoxygenation (Fig. 1c,d and Supplementary Table 2) . Similarly, immunocytochemistry in hCS cryosections indicated the expected nuclear localization of the HIF-1α protein (Fig. 1e) . At the same time, the level of cell death as estimated by cleaved caspase-3 (c-CAS3) did not significantly increase during exposure to <1% O 2 (P = 0.29; Extended Data Fig. 1b,c) , suggesting that a hypoxia-like response was induced without massive cell death. We next investigated the transcriptional changes associated with exposure to <1% O 2 by performing RNA sequencing at 24 and 48 h (middle and end of <1% O 2 exposure Letters NATurE MEDiciNE interval), as well as after 72 h of reoxygenation at 21% O 2 (Fig. 1f) . Hierarchical clustering of the gene expression profiles separated the samples exposed to <1% O 2 from unexposed samples at 24 h and 48 h, but not at 72 h after reoxygenation (time = 120 h). Together, these findings suggest that exposure to low oxygen levels resulted in a defined transcriptional profile, and that after 72 h at atmospheric oxygen, hCS reverted to their expression state before exposure to low oxygen (Extended Data Fig. 2a ). To identify genes associated with the response to low oxygen we identified genes differentially expressed between the hCS exposed <1% O 2 and the hCS exposed to 21% O 2 . We tested and controlled for potential confounding variables, such as genetic background, differentiation batch and RNA sequencing (RNA-seq) quality metrics (Methods). In total, we identified 943 differentially expressed genes at 24 h, 1,520 differentially expressed genes at 48 h and no differentially expressed genes after 72 h of reoxygenation ( Fig. 1f ; false discovery rate (FDR) ≤ 0.05, fold change ≥ 1.5; hCS from three hiPS cell lines in two differentiation experiments; Supplementary Table 3) . Among the differentially expressed genes were transcripts associated with a hypoxic response, such as PLOD2 (P = 0.006), PFKP (P = 0.008), PDK1 (P = 0.0005) and IGFBP2 (P = 0.0002) (Fig. 1f) , which we validated by quantitative PCR (qPCR) (Extended Data Fig. 2b and Supplementary Table 4) . Interestingly, we also observed several genes associated with dorsal forebrain progenitors, such as EOMES (also known as TBR2) (P = 0.006) and EMX1 (P = 0.02), as well as the cell cycle-related genes ASPM (P = 0.002) and CENPF (P < 0.0001) ( Fig. 1f and Extended Data Fig. 2c ). To gain insights into potential cell-type-specific changes following exposure to low oxygen, we assessed whether the combined set of differentially expressed genes was enriched for genes identified as being specifically expressed in laser-microdissected regions of the developing human cortex 16 . Overlap of the hypoxia-induced differentially expressed in hCS (1,754 unique genes) and subregions of the human cerebral cortex at PCW 21 revealed twofold enrichment for transcripts specifically expressed in the subventricular zone (SVZ) (P < 10 -7
; Fig. 1g ), a proliferative region bordering the ventricular epithelium that has undergone significant expansion in primates 6 and where proliferation and neurogenesis continue until later stages of gestation [12] [13] [14] . On the basis of this observation, we next assessed whether exposure of hCS to low oxygen is associated with changes in the cortical . At days 74-78 of in vitro differentiation, hCS are exposed for 48 h to <1% O 2 in a gas-controlled culture chamber and then maintained for another 72 h at 21% O 2 . Control hCS are maintained at 21% O 2 throughout. b, Oxygen tension levels (Po 2 , mmHg) measured with an optical sensor (100 and 500 μm) at 21% O 2 (n = 6 hCS) and after 48 h of exposure to <1% O 2 (n = 7); hCS from three hiPS cell lines; Kruskal-Wallis test, P < 0.0001, Dunn's multiple-comparison test, **P = 0.002 at hCS surface, **P = 0.008 at 100 µm, **P = 0.01 at 500 µm. c,d, Representative western blots and quantification of HIF-1α protein expression in hCS after 48 h of exposure to <1% O 2 and after 72 h of reoxygenation versus the unexposed samples (21% O 2 ); normalized to β-actin (n = 5 differentiated hiPS cell lines with at least two hCS per condition; Friedman's test, P = 0.02, Dunn's multiple-comparison test versus 21% O 2 , *P = 0.02 for 48 h and P > 0.99 for 72 h). Data are mean ± s.e.m. Individual values are indicated by dots. Western blots were cropped to show the relevant bands; molecular weight markers are indicated on the left (in kDa). See Supplementary Table 2 for quantifications, and uncropped blots are available as source data. e, Representative immunostaining of HIF-1α (yellow) in hCS exposed for 48 h to <1% O 2 versus 21% hCS. Experiment performed in two hiPS cell lines. Nuclei labeled by Hoechst staining. f, Volcano plots showing the results of RNA-seq experiments after exposure to <1% O 2 for 24 h or 48 h versus 21% O 2 , as well as after 48 h of exposure to <1% O 2 followed by 72 h of reoxygenation (total time of 120 h). Each dot represents a single gene, with genes that are significantly upregulated shown in red, genes that are significantly downregulated in blue and non-significant genes in gray (determined on the basis of FDR ≤ 0.05 and fold change ≥ 1.5). The size of the points corresponds to the difference in expression level between low-oxygen-exposed hCS and unexposed hCS (difference of medians); n = 24 samples from hCS derived from three hiPS cell lines. g, Overlap between hypoxia-related transcriptome changes in hCS and layer-specific transcriptome signatures in the developing human cortex at PCW 21 as described in ref. 16 . Strong enrichment is observed only in SVZ (P value corrected for multiple-comparisons (Fig. 2a,b) . These regions are surrounded by an intermediate region rich in TBR2 + cells resembling the SVZ, which is in turn surrounded by a cortical plate region containing mostly deep-layer neurons expressing the marker CTIP2 (also known as BLC11B). We used immunocytochemistry in hCS cryosections for PAX6, TBR2 and CTIP2 to delineate the proliferative VZ-like and SVZ-like regions from the cortical plate-like domain, as previously described in a cortical organoid system 17 . We quantified data from hCS derived from three hiPS cell lines in independent differentiations and observed that the density of TBR2 + cells per proliferative region was reduced by approximately 35% in hCS exposed for 48 h to <1% O 2 (left, P < 0.0001; right, P = 0.03), and this trend persisted at 72 h after reoxygenation (left, P = 0.0003; right, P = 0.06) (Fig. 2c) . By contrast, the density of PAX6 + cells in the same delineated regions was not affected after 48 h of exposure to low oxygen (left, P = 0.44; right, P > 0.99; Fig. 2d) , and the overall density of cells labeled with the nuclear dye Hoechst was unchanged (left, P = 0.09; right, P = 0.50; Extended Data Fig. 3a) . This reduction in TBR2
+ cells, but not in PAX6 + cells, was also observed when we counted the raw, total number of TBR2 + (left, P < 0.0001; right, P = 0.03) or PAX6
+ (left, P = 0.44; right, P = 0.25) cells out of all Hoechst-labeled nuclei in multiple whole cryosections of hCS (Extended Data Fig. 3b,c) . Moreover, the affected population of TBR2 + cells was not the population of SVZ progenitors coexpressing SOX2 as investigated before in a mouse model 18 (left, P = 0.82; right, P = 0.06; Extended Data Fig. 3d ).
To gain insights into this potential cell-type-specific vulnerability of cortical progenitors following exposure to low oxygen, we turned back to the hypoxia-induced transcriptional changes in hCS. It has previously been demonstrated that the transcriptome has a reproducible coexpression structure that provides a framework for understanding disease biology 19, 20 . Therefore, we applied weighted gene coexpression network analysis (WGCNA) 21 to identify modules of genes that changed with similar patterns following exposure to low oxygen in hCS (Fig. 3a) . WGCNA identified nine gene coexpression modules correlated with low-oxygen exposure (FDR ≤ 0.05). These are referred to by color label identifiers; each represents a cluster of genes with a common expression pattern across samples (Extended Data Fig. 4a,b ). Blue and turquoise were the most strongly associated modules ( Fig. 3b and Extended Data Fig. 4a,b) . The blue module is enriched for genes associated with the hypoxic response pathway and genes regulated by HIF-1α (Extended Data Fig. 4c ; FDR ≤ 0.0001). By contrast, the turquoise module was enriched for genes associated with the UPR, such as PERK (P = 0.03), ATF3 (P = 0.03) and XBP1s (P = 0.04). Analysis by qPCR confirmed these changes (Extended Data Fig. 4d and Supplementary Table 4) .
The UPR pathway is a protective cellular response induced during periods of cellular stress that aims to restore protein homeostasis 22 . In certain cancer cells, hypoxia can activate components of the UPR pathway 23 . Interestingly, previous work has linked the UPR to the generation of Tbr2 + intermediate progenitors in rodents 24 . To verify whether the transcriptional changes in the UPR pathway are relevant to the TBR2-related phenotype after exposure to low oxygen, we exposed hCS to a potent small molecule called integrated stress response inhibitor (ISRIB), which reverses with high specificity the effects of eukaryotic initiation factor 2α phosphorylation and restores protein translation while maintaining some of the protective effects of the integrated cellular response and the UPR [25] [26] [27] . We observed that adding 10 nM ISRIB during the 48 h of exposure of hCS to <1% O 2 restored the density of TBR2
+ cells (left, P = 0.30; right, P = 0.45 for <1% O 2 with ISRIB versus 21% O 2 ; Fig. 3c ). Moreover, while the UPR-pathway-related transcription factor ATF4 was coexpressed by a larger proportion of TBR2
+ cells in hCS exposed to low oxygen for 48 h versus hCS maintained at 21% O 2 , this effect was restored with 10 nM ISRIB (left and right, P > 0.99) and was partially restored 72 h after reoxygenation (left, P = 0.001; right, P = 0.51) (Fig. 3d,e) . At the same time, radial glia expressing PAX6 did not show an increase in ATF4 coexpression (left, P = 0.70; right, P = 0.48), and this remained unchanged by exposure to ISRIB (left, P = 0.54; right, P = 0.21) (Extended Data Fig. 5a ). To further investigate the role of UPR, we exposed hCS for 48 h to 1.2 μM tunicamycin, which has been shown to induce the UPR in the developing brain 28 . Similarly to exposure to low oxygen, tunicamycin reduced the proportion of TBR2 + cells (left, P < 0.0001; right, P = 0.01; Fig. 3f ). Moreover, the proportion of PAX6
+ cells was not affected by exposure to tunicamycin (left, P = 0.37; right, P = 0.20; Extended Data Fig. 5b ). Together, these experiments indicate that a 48 h exposure to low oxygen leads to a reduction in TBR2
+ intermediate progenitors but not in PAX6
+ radial glia, and that this phenotype can be prevented by simultaneous exposure to a nanomolar concentration of a UPR-pathway modulator.
We did not observe significant cell death in hCS after 48 h of hypoxia (Extended Data Fig. 1b ) (Fig. 1f) . Therefore, we explored whether this reduction is related to changes in the cell cycle. Co-staining with p27, a protein that regulates G1 and helps cells withdraw from the cell cycle when they terminally differentiate, showed a 2.4-fold increase in the overlap with TBR2 + cells following exposure to low oxygen (left, P < 0.0001; right, P = 0.0006), and this effect was prevented by simultaneous exposure to ISRIB (left, P = 0.54; right, P = 0.43) (Fig. 3g,h ). At the same time, 
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+ radial glia in hCS coexpressed p27, and this proportion did not change after oxygen deprivation (left, P = 0.88; right, P = 0.67) or ISRIB exposure (left, P = 0.90; right, 0.94) (Extended Data Fig. 5d ). To explore whether this increase in p27 expression was associated with changes in proliferation, we costained TBR2 + cells with the cell cycle marker Ki67 (left, P = 0.91; right, P = 0.91) and the mitotic marker PH3 (left, P = 0.55; right, P = 0.56) but did not find differences after exposure to low oxygen (Extended Data Fig. 5e-g ). Alternatively, these changes in p27 may be associated with cell cycle exit and early neural differentiation. Therefore, we quantified the percentage of TBR2 + cells that coexpressed the cortical marker CTIP2 and found an increase by approximately 50% in double-positive cells (left, P < 0.0001; right, P = 0.0002), which was prevented by exposure to 10 nM ISRIB (left, P = 0.58; right, P = 0.96) (Fig. 3i ). This suggests that TBR2 + cells may be particularly susceptible to premature differentiation after exposure to low oxygen levels and that modulators of the UPR pathways could be used to restore hypoxia-related defects in cortical progenitor subtypes.
Finally, to validate these findings in a more physiological system, we used primary human cortical tissue at PCW 20, which we sectioned and then exposed to either <1% O 2 
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NATurE MEDiciNE a gas-controlled environmental chamber (Fig. 4a,b) . Western blot analysis showed that HIF-1α protein stabilized at 48 h in low oxygen (P = 0.003) and this effect was present even after simultaneous exposure to 10 nM ISRIB (P = 0.0007) (Fig. 4c,d and Supplementary Table 2 ). We next performed immunostaining for PAX6 and TBR2 in cortical slices to delineate the proliferative VZ-like and SVZlike + outer SVZ-like areas (Fig. 4e) . We found a decrease in the proportion of TBR2 + cells following exposure to low oxygen (P = 0.02) and this was prevented by simultaneous exposure to 10 nM ISRIB (P = 0.69) (Fig. 4f) . At the same time, the proportion of PAX6
+ cells was unchanged in the absence (P = 0.23) or presence (P = 0.12) of ISRIB (Fig. 4g) .
In this study, we show how hiPS cell-derived 3D brain cultures can be used to model injury in the developing brain. There are several new aspects to this work. First, we used a reproducible brainregion-specific organoid model that recapitulates key features of the mid-gestation human cortex [8] [9] [10] , and we validate our findings in slices of human cortex. This platform could serve both as a model of hypoxic encephalopathy of prematurity and as a model of second-trimester placental insufficiency. Recent data in human brain tissue have demonstrated continued neurogenesis into the third trimester of pregnancy [12] [13] [14] . In fact, the risk for encephalopathy of prematurity is highest in extremely preterm infants and the neurodevelopmental consequences are most severe for this patient population 4 .
Second, we find that TBR2 + progenitors, a population of amplifying cells that reside in the SVZ and that are thought to contribute to expansion of the neocortex by increasing neuron number, are particularly affected by oxygen deprivation. In fact, TBR2
+ progenitors are positioned close to blood vessels 29 , and increased oxygen tension in the rodent cortex results in expansion of the SVZ 18 . While other studies have investigated the role of oxygen on dissociated human radial glia 30 , the effect of hypoxia on human TBR2
+ progenitors has not been explored. Future studies using this system should investigate the susceptibility of outer radial glia, which are more transcriptionally similar to radial glia but reside in the expanded outer SVZ in humans 31 . Moreover, it remains to be established how changes in specific progenitors affect brain development, as previous studies in premature brains have indicated an impact on glutamatergic neurogenesis and gray matter 14 . Third, we find that these cell-type-specific defects are related to the UPR, and in particular to the PERK-eIF2α-ATF4 pathway. This endoplasmic reticulum stress-response pathway controls protein homeostasis and has been associated with hypoxia in cancer 23 and more recently with cortical development 32 . Components of the UPR pathway correlate with milestones in corticogenesis, and changes in the UPR in rodents affect Tbr2 + cells 24 . More specifically, loss of a component of the elongator complex leads to impaired translation speed, triggers the UPR and reduces the number of Tbr2 + cells 24 . Therefore, hypoxiarelated UPR changes in intermediate progenitors could result in 
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cell-cycle changes and premature neural differentiation. Fourth, we show that the UPR modulator ISRIB-a small molecule with good pharmacokinetic properties that permeates the blood-brain barrier 25 -prevents the oxygen-related TBR2 defects in hCS and in human tissue. Future studies should validate this effect in other models to evaluate translational potential and investigate the effect of genotype on hypoxia susceptibility and recovery.
There are several limitations to our study. Our hCS system does not include immune cells and is not vascularized, and therefore the inflammation component of encephalopathy of prematurity is not captured here 33 . Future assembloid models could incorporate microglia and other cells 34 to study their contributions to encephalopathy of prematurity. Although oxygen concentration in the cerebral circulation increases following premature birth 35 and our goal was to model postnatal hypoxia in the premature brain, hCS derivation and maintenance are pursued at atmospheric oxygen levels. We have shown that hCS can be maintained in vitro for hundreds of days to model late stages of development to include astrocytes that resemble primary postnatal astrocytes 11 . Therefore, future studies could use this system to model brain injury at later in utero stages. Postmortem studies have indicated a significant loss of GABAergic interneurons in premature infants 36, 37 . Our current model does not include interneurons, which are born in the ventral forebrain and have to migrate dorsally to integrate into cortical circuits 38 . Therefore, future studies could use forebrain assembloids that combine dorsal and ventral forebrain organoids to model migration 39 . Similarly, organoid models that include oligodendrocytes together with astrocytes and neurons could be combined with the hypoxia platform we are describing to model myelination defects 40 . The use of 3D brain organoids or assembloids holds great promise for the study of the interaction of environmental factors impacting brain development. Moreover, this personalized, scalable human system could dissect individual susceptibility and protective factors and therefore may ultimately identify therapeutics strategies to bridge the disconnect between medical advances and neurodevelopmental outcomes in neonatology.
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Methods
Culture of hiPS cells. The hiPS cell lines used in this study were validated using standardized methods as previously described 9, 39, 41 . Cultures were tested for mycoplasma and maintained mycoplasma free. A total of five control hiPS cell lines were derived from fibroblasts collected from four subjects (three males and one female). Approval for this study was obtained from the Stanford IRB panel and informed consent was obtained from all subjects.
Generation of hCS from hiPS cells. hiPS cells were cultured on inactivated mouse embryonic fibroblast feeders (EmbryoMax PMEF; Millipore) in hiPS cell medium containing DMEM/F12 (1:1, Life Technologies, 11330), knockout serum (20%, Life Technologies, 10828), non-essential amino acids (1 mM, Life Technologies, 11140), GlutaMax (1: 200, Life Technologies, 35050), β-mercaptoethanol (0.1 mM, Sigma-Aldrich, M3148), penicillin and streptomycin (1:100, Life Technologies, 15070), and supplemented with fibroblast growth factor 2 (10 ng ml −1 diluted in 0.1% BSA; R&D Systems). The generation of hCS from hiPS cells was performed as previously described 9 . To initiate the generation of hCS, intact hiPS cell colonies were lifted from the plates using dispase (0.35 mg ml −1 ) and transferred to ultralowattachment plastic dishes (Corning) in hiPS cell medium supplemented with the two SMAD inhibitors dorsomorphin (5 μM, Sigma-Aldrich) and SB-431542 (10 μM, Tocris) and the ROCK inhibitor Y-27632 (10 μM, EMD Chemicals). For the first 5 d, the hiPS cell medium was changed every day and supplemented with dorsomorphin and SB-431542. On the sixth day in suspension, neural spheroids were transferred to neural medium containing neurobasal-A (Life Technologies, 10888), B-27 supplement without vitamin A (Life Technologies, 12587), GlutaMax (1:100, Life Technologies), penicillin and streptomycin (1:100, Life Technologies) and supplemented with the growth factors epidermal growth factor (20 ng ml −1 ; R&D Systems) and fibroblast growth factor 2 (20 ng ml
; R&D Systems) until day 24. From day 25 to day 42, the neural medium was supplemented with the growth factors brain-derived neurotrophic factor (20 ng ml , Peprotech) with medium changes every other day. From day 43 onward, hCS were maintained in unsupplemented neural medium with medium changes every 4-6 d. A step-by-step protocol describing hCS generation can also be found in ref. 8 .
Exposure of hCS to low oxygen. Human cortical spheroids derived from five hiPS cell lines (four individuals) were used for low-oxygen exposure in a total of nine independent experiments. At 74-78 d of in vitro differentiation, hCS maintained in 21% O 2 and 5% CO 2 were transferred to a C-chamber hypoxia sub-chamber (Biospherix) in neural medium (without growth factors) for 48 h. The medium was previously equilibrated for approximately 16 h at <1% O 2 , 5% CO 2 and 37 °C. The level of oxygen was controlled using a Proox 110 Compact Oxygen Controller (Biospherix) and a mixed CO 2 /N 2 compressed gas source. After 48 h, hCS were immediately collected for analyses or transferred to an incubator with 21% O 2 and 5% CO 2 for another 72 h (reoxygenation condition).
Exposure of hCS to tunicamycin. At 74-78 d of in vitro differentiation, hCS were exposed to 1.2 μM tunicamycin (Sigma, T7765) for 48 h at 21% O 2 and 5% CO 2 . After 48 h, hCS were collected for analyses as described for the hypoxia experiments.
Oxygen tension measurements. The oxygen optical microsensor OXB50 (50 μm, PyroScience) was used to measure oxygen tension in hCS. This sensor measures changes in oxygen tension by calculating the quenching of a probe (Red Flash Dye) situated at the tip of the sensor. The probe is excited with red light at a wavelength of 610-630 nm and shows an oxygen-dependent luminescence in the near-infrared spectrum (760-790 nm). A two-point calibration was performed before measurements. Pure nitrogen gas and ambient air were set as 0 and 100% air saturation. Optical signals were sampled and digitized by the compatible meter of the sensor (FireStingO2, PyroScience) and Oxygen Logger software (PyroScience).
To determine the oxygen levels at various depths, we mounted the sensor on a micromanipulator with a high-precision slide (<0.1-μm axial resolution) and applied 50-μm steps from the hCS surface toward the center.
Human tissue. Human tissue was obtained under a protocol approved by the Research Compliance Office at Stanford University. The tissue was immediately placed in RPMI medium and processed within 16 h of collection using a previously adapted protocol 42 . In brief, PCW 20 frontal brain tissue was embedded in 4% low-melting-point agarose in PBS and cut using a scalpel to obtain 2-mm-thick sections. The sections were then placed in tissue culture plates containing culture medium (66% BME, 25% Hanks, 5% FBS, 1% N-2, 1% penicillin, streptomycin and glutamine; all from Invitrogen) and 0.66% d-(+)-glucose (Sigma-Aldrich) and incubated in standard conditions (21% O 2 , 5% CO 2 , 37 °C) for 24 h. Sections were subsequently exposed to <1% O 2 and 5% CO 2 in a chamber or maintained in 21% O 2 and 5% CO 2 for 48 h. Samples were then collected and processed for analyses.
Cryopreservation. Human cortical spheroids were fixed in 4% paraformaldehyde overnight. They were then washed in PBS and transferred to 30% sucrose for 48-72 h. Subsequently, they were transferred into embedding medium (Tissue-Tek OCT Compound 4583, Sakura Finetek), snap-frozen on dry ice and stored at −80 °C. For immunohistochemistry, 10-μm-thick sections were cut using a cryostat (Leica).
Slices of primary cortical tissue (2 mm thick) were fixed in 4% paraformaldehyde for 48 h. They were then washed in PBS and transferred to 30% sucrose for 5 d. Subsequently, they were moved to embedding medium (1:1 mixture of 30% sucrose and Tissue-Tek OCT Compound 4583, Sakura Finetek), snapfrozen on dry ice and stored at −80 °C. For immunohistochemistry, 40-μm-thick cryosections were cut using a Leica cryostat.
Immunocytochemistry. Cryosections of hCS were washed with PBS to remove excess OCT and blocked in 10% normal donkey serum (NDS), 0.3% Triton X-100 diluted in PBS for 1 h at room temperature. The sections were then incubated overnight at 4 °C with primary antibodies diluted in PBS containing 2% NDS and 0.1% Triton X-100. PBS was used to wash off the primary antibodies and the cryosections were incubated with secondary antibodies in PBS with 2% NDS and 0.1% Triton X-100 for 1 h. After incubation with secondary antibodies, three washes of 15 min were performed in PBS. The following primary antibodies were used for immunohistochemistry: CTIP2 (rat, 1:300, Abcam, AB18465), p27 (rabbit, 1:100, Thermo Fisher Scientific, PA5-27188), ATF4 (rabbit, 1:50, Cell Signaling, D4B8, 11815), HIF-1α (mouse, 1:50, Santa Cruz sc-53546), PAX6 (rabbit, 1:300, BioLegend, PRB-278P), SOX2 (rabbit, 1:200, Cell Signaling 3579 S), PH3 (rat, 1:500, Abcam AB10543), Ki67 (rabbit, 1:100, Novus Biological NB600-1252). For TBR2 staining (anti-TBR2, mouse, 1:100; R&D, MAB6166), antigen retrieval (using 10 mM sodium citrate and heating to 95 °C) was performed for 20 min and sections were blocked in 0.1% Triton X-100, 10% serum and 0.2% gelatin for 1 h. The sections were incubated with primary antibodies in blocking buffer overnight at 4 °C, then washed with PBS and incubated with secondary antibodies diluted in blocking buffer for 1 h at room temperature. After incubation with secondary antibodies, three washes of 15 min were performed in PBS.
Cryosections of primary cortical tissue were washed with PBS to remove excess OCT. Antigen retrieval (using 10 mM sodium citrate and heating to 95 °C) was performed for 20 min. Cryosections were blocked in 0.1% Triton X-100, 10% NDS and 0.2% gelatin diluted in PBS for 4 h at room temperature. The sections were then incubated for 24 h at 4 °C with primary antibodies diluted in blocking solution. Primary antibodies were washed off with 0.5% Triton X-100 diluted in PBS for 1 h and subsequently incubated with secondary antibodies in blocking solution for 2 h at room temperature. After incubation with secondary antibodies, three washes of 20 min were performed in PBS. The following primary antibodies were used for immunohistochemistry: PAX6 (rabbit, 1:300, Biolegend, PRB-278P), TBR2 (sheep, 1:100, Novus Biologicals, AF6166).
Secondary antibodies AlexaFluor 488, 568 and 647 (donkey anti-rabbit, antirat, anti-mouse or anti-sheep) were used at a 1:500 dilution. Nuclei were visualized with Hoechst 33258 (Life Technologies, 1:10,000). Cryosections were mounted for microscopy on glass coverslips, using Aquamount (Thermo Fisher Scientific) and imaged on a Zeiss M1 Axioscope (for hCS cryosections) or a Keyence BZ-X710 microscope (for primary cortical tissue cryosections).
Immunocytochemistry quantification. The density of TBR2
+
, PAX6
+ and Hoechst + cells was estimated in 10-μm-thick hCS cryosections . The number of cells was quantified in circular areas around proliferative zones. The boundary between proliferative zones (VZ and SVZ) and cortical plate was established on the basis of the expression, cell orientation and density of nuclei (Hoechst) and PAX6 + and CTIP2
+ cells. Independently, the percentages of TBR2 + and PAX6 + cells were also quantified out of the total number of cells (Hoechst + ) in whole 10-μm-thick cryosections of hCS from multiple hiPS cell lines.
Western blot. Human cortical spheroids were rapidly lysed on ice with the RIPA lysis buffer system (Santa Cruz, sc-24948) after low-oxygen exposure. Whole-cell lysates were then separated on gels (Invitrogen, NuPAGE 4-12% Bis-Tris) and transferred to a PVDF membrane (Millipore, Immobilon-P Membrane, 0.45 μm). The membranes were incubated at 4 °C overnight with the following primary antibodies: HIF-1α (mouse, 1:1,000, BD Bioscience, 610958) β-actin (mouse, 1:20,000, Sigma, A5316) and c-CAS3 (rabbit, 1:500, Abcam, ab32042). Horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG was used as secondary antibody. Signals were developed by chemiluminescence (Amersham, ECL western blotting detection reagents, RPN2106). Bands were quantified using ImageJ software, with normalization to background and to a β-actin control. Uncropped blots of representative western blots are shown in the Source Data and values from quantification for all blots used are listed in Supplementary Table 2 .
Real-time quantitative PCR. mRNA was isolated using the RNeasy Mini kit and RNase-Free DNase set (Qiagen), and template cDNA was prepared by reverse transcription using the SuperScript III First-Strand Synthesis SuperMix for qPCR with reverse transcription (Life Technologies). Quantitative PCR was performed using Sybr Green (Roche) on a ViiA7 machine (Applied Biosystems
RNA sequencing. mRNA was isolated using the miRNeasy micro Kit and RNaseFree DNase set (Qiagen). Library preparation was conducted by Macrogen (https://www.macrogenusa.com) using the TruSeq Stranded Total RNA LT Sample Prep Kit. Samples were then sequenced on the Illumina HiSeq 4000 System using paired-end, 101-bp-long reads to a minimum of 40 million reads per sample. We used STAR v.2.5.2b (ref. 43 ) to align raw RNA-seq reads to the GRCh37 human genome reference from the Illumina iGenome Project. We generated alignment quality-control metrics with Picard (https://www.broadinstitute.github.io/picard). Principal-component analysis of these metrics did not detect outliers. We then used HTSeq 44 to generate gene-level count data, and kept transcripts with at least one read in more than 50% of the samples. The CQN R package 45 normalized the remaining 24,878 transcripts for gene length, GC content and sample library size. We further removed genes whose expression value did not change across all samples or with an average normalized expression value less than one (that is, weakly expressed genes). We screened again with principal-component analysis of normalized gene expression but did not detect outliers.
We conducted hierarchical clustering and differential gene expression analysis with normalized gene-expression values. To identify confounding variables, we used a regression model selection approach. We built negative binomial regression models to model expressions of each gene separately. A forward stepwise algorithm selected the best model, defined as the model where the Bayesian information criterion could not be improved by adding additional confounding variables. With this approach, we identified the three most impactful confounding variables: hiPS cell line, percentage of untranslated region bases and percentage of intronic bases. We used edgeR 46, 47 to identify significant genes at each of the three time points (after 24 h or 48 h of <1% O 2 and after 72 h of reoxygenation) and to remove the effects of the three confounding variables. We corrected P values for multiple comparisons using the Benjamini-Hochberg method and selected significant genes on the basis of two criteria: FDR ≤ 0.05 and at least 50% increase or decrease in expression between the control and hypoxia conditions (that is, a 1.5-fold change, up or down). As a final quality-control step, we identified genes that were differentially expressed across time in the control samples (that is, highly correlated with time) and removed them from the list of differentially expressed genes. As the fold-change threshold is somewhat arbitrary we list the entire set of genes with FDR ≤ 0.05 in the supplementary material, along with log 2 -transformed foldchanges (Supplementary Table 3 ). We combined all significant genes identified at all three time points to generate a heat map of all samples (heatmap3 R package). We used the GoSeq 48 R package as well as ToppGene 49 to identify Gene Ontology (GO) terms enriched in our significant gene list.
To examine the relationship between differential gene expression and the developing human cortex, we used layer-specific data that were previously reported for PCW 21 (ref. 16 ). We used a hypergeometric test (two-sided) to assess enrichment, and corrected P values for multiple comparisons using the Bonferroni correction. We determined the background for these calculations as the number of genes overlapping between our RNA-seq data and the data reported in Miller et al. 16 . To ensure that our choice of a 1.5-fold-change threshold did not affect the results of these analyses, we also conducted exploratory analyses to assess whether the enrichment for SVZ transcripts was robust at different thresholds. We observed that this enrichment was stable across a wide range of fold-change thresholds (approximately 1.3-fold to 2.5-fold-change).
We conducted gene coexpression analysis following normalization for gene length and GC content (using CQN; see above). The WGCNA 50 R package computed an unsigned similarity matrix with a softpower of 12. We created gene modules on the basis of hierarchical clustering results of the similarity matrix and summarized the 'average' expression of all the genes in a given module with the first principal component of module expression (module 'eigengene'). We then evaluated the relationship between these gene modules and experimental conditions (that is, oxygen tension) by computing correlation coefficients to the first principal component. We identified a total of nine significant gene coexpression modules based on two cutoffs: correlation coefficient ≥ 0.9 and FDR ≤ 0.05. We conducted GO enrichment analysis of the genes in each of these nine significant modules with the R package GoSeq 48 . Only two modules were significantly enriched for GO terms after FDR correction: the blue and turquoise modules.
Statistics. Data are presented as mean ± s.e.m., unless otherwise indicated. Distributions of the raw data were tested for normality of distribution; statistical analyses were performed accordingly using paired or unpaired t-test (two sided), Mann-Whitney U test, Wilcoxon rank-sum test, or the Friedman or ANOVA test with multiple-comparison correction as indicated. Sample sizes were estimated empirically. GraphPad Prism v.7 was used for statistical analyses. ) . b,c, Validation by qPCR of hypoxia-related genes PLOD2 (two-tailed paired t-test, **P = 0.006), PFKP (two-tailed paired t-test, **P = 0.008), PDK1 (two-tailed paired t-test, ***P = 0.0005) and IGFBP2 (two-tailed paired t-test, ***P = 0.0002), and cortical progenitor and cell cycle-related genes EOMES (also known as TBR2) (two-tailed paired t-test, **P = 0.006), EMX1 (two-tailed paired t-test, *P = 0.02), ASPM (two-tailed paired t-test, **P = 0.002) and CENPF (two-tailed paired t-test, ****P < 0.0001), which were identified in the RNA-seq analysis (n = 4 hiPS cell lines differentiated; each line is shown in a different color; expression normalized to the RPL13a housekeeping gene). Data are the mean ± s.e.m. Individual values are indicated by dots. 
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